Eric A Espiner Selected Research

atrial natriuretic factor receptor C

2/2015	C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
4/2006	Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric A Espiner Research Topics

Disease

15	Heart Failure 01/2019 - 01/2002
4	Acute Coronary Syndrome 01/2020 - 06/2003
3	Achondroplasia 01/2022 - 02/2015
3	Myocardial Infarction 01/2017 - 04/2002
2	Thanatophoric Dysplasia (Dwarfism, Thanatophoric) 01/2022 - 02/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2017
2	Inflammation (Inflammations) 10/2019 - 08/2013
2	Heart Diseases (Heart Disease) 01/2019 - 05/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 05/2002
2	Maroteaux type Acromesomelic dysplasia 02/2015 - 04/2006
2	Hypertension (High Blood Pressure) 06/2003 - 04/2002
1	Chronic Renal Insufficiency 10/2019
1	Parkinson Disease (Parkinson's Disease) 10/2017
1	Unstable Angina 01/2017
1	Coronary Disease (Coronary Heart Disease) 01/2017
1	Dwarfism 02/2015
1	Klinefelter Syndrome (Klinefelter's Syndrome) 11/2012
1	Osteonecrosis (Kienbock's Disease) 07/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2012
1	Hyperthyroidism 06/2012
1	Malnutrition (Nutritional Deficiencies) 08/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2006
1	Ventricular Remodeling 04/2002
1	Infarction (Infarctions) 04/2002

Drug/Important Bio-Agent (IBA)

12	Natriuretic PeptidesIBA 01/2020 - 01/2002
11	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2022 - 12/2002
7	NTproCNPIBA 01/2022 - 11/2012
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 12/2002
6	Peptides (Polypeptides)IBA 08/2013 - 05/2002
5	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 01/2006
4	Atrial Natriuretic Factor (ANF)IBA 01/2017 - 12/2002
4	Hormones (Hormone)IBA 06/2004 - 05/2002
3	CreatinineIBA 10/2019 - 06/2003
3	UrocortinsIBA 10/2005 - 10/2002
3	AldosteroneIBA 10/2005 - 01/2002
3	AdrenomedullinIBA 11/2002 - 01/2002
2	C-Reactive ProteinIBA 01/2020 - 08/2013
2	atrial natriuretic factor receptor BIBA 02/2015 - 04/2006
2	atrial natriuretic factor receptor CIBA 02/2015 - 04/2006
2	Endothelins (Endothelin)IBA 10/2005 - 06/2004
2	Radioisotopes (Radionuclides)IBA 06/2003 - 04/2002
2	Vasodilator Agents (Vasodilators)IBA 11/2002 - 01/2002
1	CollagenIBA 01/2022
1	vosoritideIBA 12/2021
1	Atorvastatin (Lipitor)FDA Link 01/2020
1	LipidsIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	AlbuminsIBA 10/2019
1	4-nitrophenylphosphorylcholine (NPPC)IBA 10/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2015
1	SteroidsIBA 07/2012
1	Biomarkers (Surrogate Marker)IBA 07/2012
1	Thyroid HormonesIBA 06/2012
1	CarbimazoleIBA 06/2012
1	CRF receptor type 2IBA 10/2005
1	ReninIBA 10/2005
1	Angiotensin IIIBA 06/2004
1	CholesterolIBA 06/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2003
1	SodiumIBA 11/2002
1	HemaccelIBA 11/2002
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2002
1	Captopril (Capoten)FDA LinkGeneric 06/2002
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2002
1	TroponinIBA 05/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2002
1	EndopeptidasesIBA 01/2002

Therapy/Procedure

4	Therapeutics 12/2021 - 05/2004
2	Drug Therapy (Chemotherapy) 07/2012 - 06/2003
1	Intravenous Infusions 10/2005